Rutherford well placed to accelerate growth after 30% jump in revenue

The Rutherford Cancer Centre North East

Cancer treatment specialist Rutherford Health has said it is well positioned to drive meaningful growth in the short to medium term after booking a 30% jump in revenue to £7.3m for the year ended 28 February 2021. CEO Mike Moran said the Covid-19 pandemic had tested the company’s resilience and demonstrated the underlying strength of…

You must be a HM Subscriber to view this content.

Subscribe Now »